Thinfilm and GSK Bring NFC Technology to Brand Flonase

Thin Film Electronics announced that GlaxoSmithKline has commercially deployed SpeedTap tags. That will enable them to create interactive smart shelves for enhanced communication with consumers at time of purchase decision-making.

GSK introduced interactive smart Flonase shelves in retail stores across Canada in an effort to educate consumers about the new product and guide them in their purchasing decision. Thinfilm’s SpeedTap tags incorporated into shelving allows consumers to obtain product information through the tap of an NFC-enabled smartphone.

In addition to SpeedTap tags, GSK is also using Thinfilm’s software platform CNECT as part of the end-to-end solution that helps dynamically manage the experience of Flonase consumers. The cloud-based platform integrates with the NFC hardware, enabling GSK to manage tags remotely, deliver custom messaging and content, view real-time consumer tapping activity, and develop valuable consumer insights through built-in analytics functionality.

“At GSK, we focus on helping people do more, feel better, and live longer. And we do that, in large part, by delivering highly effective products to the market. But we also realize that connecting directly with consumers is critical in today’s market. We believe an innovative mobile technology can play a critical role in strengthening customer relationships, building brand loyalty, and driving revenue,“ said Sriman Banerjee, Director R&D Respiratory Packaging for GSK.

“We are delighted to work with GSK. Bringing Thinfilm’s NFC solutions to a valued product like Flonase is a milestone in the industry, and we look forward to helping GSK drive the brand’s value by connecting directly with consumers at the time of purchase decision-making,“ said Davor Sutija, CEO of Thinfilm.